 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Research > Transgenomic, Inc.
 |
Transgenomic, Inc. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
RESEARCH ALERT-Transgenomic started as buy Jul 18 2001 08:58 AM PDT
> More WIRE STORIES about this company
PROFILE |
 |
Mutants can't hide from Transgenomic. The firm's WAVE System -- which includes a separation column, proprietary software, and reagents and other consumables -- allows researchers to quickly identify DNA mutations (known as single nucleotide polymorphisms, or SNPs). Customers include such institutions as Harvard University and the National Institutes of Health, as well as major drug companies such as Eli Lilly, Bristol-Myers Squibb, Merck, and Novartis. Founded in 1985 as CETAC Technologies, a maker of nebulizers, the company grew via acquisitions and became Transgenomic in 1997. CEO and founder Collin D'Silva and his father Arthur own nearly 30% of Transgenomic.
COMPETITION |
 |
APBiotech Inc (dossier)
Applera Corporation (dossier)
Bio-Rad Laboratories, Inc. (BIO)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 25.90
1-Yr. Sales Growth: 12.4%
Employees: 188
Revenue per employee: $137,765.96
KEY PEOPLE |
 |
Collin J. D'Silva
CEO
Gregory J. Duman
CFO
CONTACT INFO |
 |
12325 Emmet St.
Omaha, NE 68164
US
Phone: 402-452-5400
Fax: 402-452-5401
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |